Delivery Order SPE2DB20D1004-SPE2DB25F1697
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication used for acute repetitive seizure clusters, representing a specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,688.89 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on August 13, 2025, with completion scheduled for August 14, 2025. This firm fixed-price delivery order, issued without set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizure episodes in patients with epilepsy, representing a critical specialty...
- The Defense Logistics Agency awarded a delivery order valued at $9,124.26 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays. This firm fixed-price contract, with an ultimate completion date of August 20, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute seizure management, reflecting the Department of Defense's ongoing...
- The Defense Logistics Agency awarded a delivery order valued at $1,128.54 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays on August 20, 2025, with an ultimate completion date of August 21, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed from the vendor's facility in Conshohocken, Pennsylvania. Valtoco is a FDA-approved rescue medication indicated for acute repetitive seizures, supporting military and federal healthcare system...
- The Defense Logistics Agency awarded a delivery order valued at $4,107.10 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used to treat acute seizure clusters in epilepsy patients,...
- The Defense Logistics Agency awarded a delivery order valued at $4,504.40 to AmerisourceBergen Drug Corp for Valtoco 5 mg nasal sprays on July 23, 2025, with an ultimate completion date of July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication indicated for acute repetitive seizures, representing specialized...
- The Defense Logistics Agency awarded a delivery order valued at $1,129.62 to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays, with an ultimate completion date of August 12, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded on August 11, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a rescue medication used for acute repetitive seizure clusters in epilepsy...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal sprays valued at $3,967.95 under a firm fixed price contract type. The award was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a non-set-aside competitive award, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. Valtoco is a seizure rescue medication, reflecting the federal government's...
- The Defense Logistics Agency awarded a delivery order valued at $1,141.96 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal spray on July 29, 2025, with a completion date of July 30, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Valtoco is a nasal spray formulation used for acute seizure management, reflecting the breadth of...
- The Defense Logistics Agency awarded a $1,747.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Valtoco 10 mg nasal spray, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract was issued on August 11, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. Valtoco is a prescription nasal spray medication used for acute seizure management, representing a specialized...
- SPE2DB20D1004Indefinite Delivery Contract
- SPE2DB20D1004-SPE2DB25F1697Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,369.59 to AmerisourceBergen Drug Corp for Valtoco 15 mg nasal sprays, with an ultimate completion date of September 4, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania facility. Valtoco is a rescue medication used in acute seizure management, representing the specialized pharmaceutical products that support military and federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime contract vehicle that extends through December 2026. The parent IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support Defense Health Agency operations and other federal healthcare programs globally. The company's extensive federal contract portfolio demonstrates its established capability to meet competitive procurement requirements for critical medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/3/25 |